Background
The authors conducted this series to assess the role of sleeve gastrectomy in the management of type II diabetic patients because the available evidence on its significance in this regard is still lacking.
Patients and methods
The authors conducted our research on 40 type II diabetic morbidly obese patients between August 2020 and December 2021, who underwent laparoscopic sleeve gastrectomy and evaluated for the glycemic control regarding glycosylated hemoglobin and fasting blood glucose levels together with the degree of success of excess body weight loss.
Results
At a 12-month follow-up, 80% of patients had shown remission of diabetes without drug use and none of the seven patients who used to take insulin preoperatively needed to continue on it. Male patients, those who had greater preoperative levels of glycosylated hemoglobin, those who were diagnosed with diabetes since 5 years or more, those with minimal extra body weight loss, and those requiring insulin for diabetic control preoperatively had lower postoperative remission rates.
Conclusion
Type II diabetic obese patients can show remission of diabetes without drug use or at least improved glycemic control to a great extent after sleeve gastrectomy.